Hsu DS - Search Results

1

A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer.

Chung SY, Chang YC, Hsu DS, Hung YC, Lu ML, Hung YP, Chiang NJ, Yeh CN, Hsiao M, Soong J, Su Y, Chen MH. Chung SY, et al. Among authors: hsu ds. Neoplasia. 2023 Jan;35:100856. doi: 10.1016/j.neo.2022.100856. Epub 2022 Nov 25. Neoplasia. 2023. PMID: 36442297 Free PMC article.

2

PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy.

Tan KT, Yeh CN, Chang YC, Cheng JH, Fang WL, Yeh YC, Wang YC, Hsu DS, Wu CE, Lai JI, Chang PM, Chen MH, Lu ML, Chen SJ, Chao Y, Hsiao M, Chen MH. Tan KT, et al. Among authors: hsu ds. J Immunother Cancer. 2020 Mar;8(1):e000485. doi: 10.1136/jitc-2019-000485. J Immunother Cancer. 2020. PMID: 32238472 Free PMC article.

3

Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway.

Chung SY, Hung YP, Pan YR, Chang YC, Wu CE, Hsu DS, Chang PM, Lu ML, Huang CF, Su Y, Hsiao M, Yeh CN, Chen MH. Chung SY, et al. Among authors: hsu ds. Biomedicines. 2021 Jul 24;9(8):885. doi: 10.3390/biomedicines9080885. Biomedicines. 2021. PMID: 34440089 Free PMC article.

4

Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance.

Cheng HY, Hsieh CH, Lin PH, Chen YT, Hsu DS, Tai SK, Chu PY, Yang MH. Cheng HY, et al. Among authors: hsu ds. J Immunother Cancer. 2022 Aug;10(8):e004832. doi: 10.1136/jitc-2022-004832. J Immunother Cancer. 2022. PMID: 36002186 Free PMC article.

5

Chromosome instability modulated by BMI1-AURKA signaling drives progression in head and neck cancer.

Chou CH, Yang NK, Liu TY, Tai SK, Hsu DS, Chen YW, Chen YJ, Chang CC, Tzeng CH, Yang MH. Chou CH, et al. Among authors: hsu ds. Cancer Res. 2013 Jan 15;73(2):953-66. doi: 10.1158/0008-5472.CAN-12-2397. Epub 2012 Nov 30. Cancer Res. 2013. PMID: 23204235

6

Lymphotoxin-β Interacts with Methylated EGFR to Mediate Acquired Resistance to Cetuximab in Head and Neck Cancer.

Hsu DS, Hwang WL, Yuh CH, Chu CH, Ho YH, Chen PB, Lin HS, Lin HK, Wu SP, Lin CY, Hsu WH, Lan HY, Wang HJ, Tai SK, Hung MC, Yang MH. Hsu DS, et al. Among authors: hsu wh. Clin Cancer Res. 2017 Aug 1;23(15):4388-4401. doi: 10.1158/1078-0432.CCR-16-1955. Epub 2017 Feb 14. Clin Cancer Res. 2017. PMID: 28196873

7

Acetylation of snail modulates the cytokinome of cancer cells to enhance the recruitment of macrophages.

Hsu DS, Wang HJ, Tai SK, Chou CH, Hsieh CH, Chiu PH, Chen NJ, Yang MH. Hsu DS, et al. Cancer Cell. 2014 Oct 13;26(4):534-48. doi: 10.1016/j.ccell.2014.09.002. Cancer Cell. 2014. PMID: 25314079 Free article.

8

Snail-induced claudin-11 prompts collective migration for tumour progression.

Li CF, Chen JY, Ho YH, Hsu WH, Wu LC, Lan HY, Hsu DS, Tai SK, Chang YC, Yang MH. Li CF, et al. Among authors: hsu wh, hsu ds. Nat Cell Biol. 2019 Feb;21(2):251-262. doi: 10.1038/s41556-018-0268-z. Epub 2019 Jan 21. Nat Cell Biol. 2019. PMID: 30664792

9

Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition.

Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, Chang SY, Lee OK, Wu KJ. Yang MH, et al. Among authors: hsu ds. Nat Cell Biol. 2010 Oct;12(10):982-92. doi: 10.1038/ncb2099. Epub 2010 Sep 5. Nat Cell Biol. 2010. PMID: 20818389

10

Identification of increased NBS1 expression as a prognostic marker of squamous cell carcinoma of the oral cavity.

Hsu DS, Chang SY, Liu CJ, Tzeng CH, Wu KJ, Kao JY, Yang MH. Hsu DS, et al. Cancer Sci. 2010 Apr;101(4):1029-37. doi: 10.1111/j.1349-7006.2009.01471.x. Epub 2009 Dec 15. Cancer Sci. 2010. PMID: 20175780 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page